vimarsana.com

Latest Breaking News On - Glio blastoma multiforme - Page 4 : vimarsana.com

Theralase Releases Q322 Interim Financial Statements

30.11.2022 - TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) - Theralase Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic .

United statesCompany photo dynamic compoundsGood laboratory practicesNational research council of canadaTechnical services agreementDevelopment expensesCompany antiPublic health agency of canadaHealth canadaVenture exchangeRegulation services providerTheralase technologies incConsolidated statementsMuscle invasive bladder cancerAnti cancer therapyNon brokered private

Theralase ® Closes Private Placement Equity Financing

Theralase ® Closes Private Placement Equity Financing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKristina hacheyYork stock exchangeCompany photo dynamic compoundsTechnologies inc theralaseGood laboratory practiceToronto stock exchangeAmerican stock exchangeTechnologies incNew york stock exchangeCompany common shareParty transactionsVenture exchangeRegulation services providerTheralase technologies incPhoto dynamic compounds

Theralase® Closes $2 5M Private Placement Equity Financing

TORONTO, Sept. 22, 2022 (GLOBE NEWSWIRE) Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage.

United statesKristina hacheyYork stock exchangeCompany photo dynamic compoundsGood laboratory practiceToronto stock exchangeAmerican stock exchangeTechnologies incNew york stock exchangeParty transactionsCompany common shareVenture exchangeRegulation services providerPhoto dynamic compoundsEach warrantCommon share

Theralase Releases Q222 Interim Financial Statements

TORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) Theralase

United statesArkady mandelVera madzarevicCompany photo dynamic compoundsGood laboratory practicesCollaborative research agreementDevelopment expensesTechnologies incPublic health agency of canadaPostmedia network incNational microbiology laboratoryVenture exchangeRegulation services providerFinancial statementsPhotodynamic compoundsPostmedia network

Theralase Releases Q122 Interim Financial Statements

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesCompany photo dynamic compoundsGood laboratory practicesCollaborative research agreementDevelopment expensesTechnologies incPublic health agency of canadaNational microbiology laboratoryVenture exchangeRegulation services providerPhotodynamic compoundsFinancial statementsConsolidated statementsThrough designationFast track designationFast track

vimarsana © 2020. All Rights Reserved.